Matrigel plug assay: Evaluation of the angiogenic response by reverse transcription-quantitative PCR

Angiogenesis

Volumn 16, Issue 2, 2013, Pages 469-477

  Coltrini, Daniela ^a   Di Salle, Emanuela ^a   Ronca, Roberto ^a   Belleri, Mirella ^a   Testini, Chiara ^a,b   Presta, Marco ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Angiogenesis; Anti angiogenic drugs; FGF2; Matrigel; PCR; Quantification

Indexed keywords

BETA ACTIN; CD31 ANTIGEN; FIBROBLAST GROWTH FACTOR 2; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; VASCULAR ENDOTHELIAL CADHERIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BETA ACTIN GENE; BIOASSAY; CD31 GENE; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; GENE TARGETING; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE GENE; HUMAN; HUMAN CELL; IN VIVO STUDY; MARKER GENE; MATRIGEL PLUG ASSAY; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; VASCULAR ENDOTHELIAL CADHERIN GENE;

COLLAGEN; DRUG COMBINATIONS; HUMANS; IMMUNOHISTOCHEMISTRY; LAMININ; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEOGLYCANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

MURINAE; MUS;

EID: 84877787489     PISSN: 09696970     EISSN: 15737209     Source Type: Journal    
DOI: 10.1007/s10456-012-9324-7     Document Type: Article

References (23)

1. Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407:249-257
2. Ferrara N (2010) Binding to the extracellular matrix and proteolytic processing: two key mechanisms regulating vascular endothelial growth factor action. Mol Biol Cell 21:687-690
3. Presta M, Dell'Era P, Mitola S, Moroni E, Ronca R, Rusnati M (2005) Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev 16:159-178 (Pubitemid 40616114)
4. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27-31
5. Wu JM, Staton CA (2012) Anti-angiogenic drug discovery: lessons from the past and thoughts for the future. Expert Opin Drug Discov 8:723-743
6. Hasan J, Shnyder SD, Bibby M, Double JA, Bicknel R, Jayson GC (2004) Quantitative angiogenesis assays in vivo-a review. Angiogenesis 7:1-16 (Pubitemid 39127766)
7. Auerbach R, Lewis R, Shinners B, Kubai L, Akhtar N (2003) Angiogenesis assays: a critical overview. Clin Chem 49:32-40 (Pubitemid 36078551)
8. Nicoli S, Presta M (2007) The zebrafish/tumor xenograft angiogenesis assay. Nat Protoc 2:2918-2923
9. Ribatti D, Nico B, Vacca A, Presta M (2006) The gelatin sponge-chorioallantoic membrane assay. Nat Protoc 1:85-91
10. Norrby K (2006) In vivo models of angiogenesis. J Cell Mol Med 10:588-612 (Pubitemid 44874273)
11. Passaniti A, Taylor RM, Pili R, Guo Y, Long PV, Haney JA, Pauly RR, Grant DS, Martin GR (1992) A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab Invest 67:519-528
12. Kleinman HK, McGarvey ML, Hassell JR, Star VL, Cannon FB, Laurie GW, Martin GR (1986) Basement membrane complexes with biological activity. Biochemistry 25:312-318 (Pubitemid 16053790)
13. Coltrini D, Gualandris A, Nelli EE, Parolini S, Molinari-Tosatti MP, Quarto N, Ziche M, Giavazzi R, Presta M (1995) Growth advantage and vascularization induced by basic fibroblast growth factor overexpression in endometrial HEC-1-B cells: an export-dependent mechanism of action. Cancer Res 55:4729-4738
14. Dong QG, Bernasconi S, Lostaglio S, De Calmanovici RW, Martin-Padura I, Breviario F, Garlanda C, Ramponi S, Mantovani A, Vecchi A (1997) A general strategy for isolation of endothelial cells from murine tissues. Characterization of two endothelial cell lines from the murine lung and subcutaneous sponge implants. Arterioscler Thromb Vasc Biol 17:1599-1604 (Pubitemid 27387783)
15. Andres G, Leali D, Mitola S, Coltrini D, Camozzi M, Corsini M, Belleri M, Hirsch E, Schwendener RA, Christofori G, Alcami A, Presta M (2009) A pro-inflammatory signature mediates FGF2-induced angiogenesis. J Cell Mol Med 13:2083-2108
16. Woodfin A, Voisin MB, Nourshargh S (2007) PECAM-1: a multi-functional molecule in inflammation and vascular biology. Arterioscler Thromb Vasc Biol 27:2514-2523 (Pubitemid 350158900)
17. Compagni A, Wilgenbus P, Impagnatiello MA, Cotten M, Christofori G (2000) Fibroblast growth factors are required for efficient tumor angiogenesis. Cancer Res 60:7163-7169 (Pubitemid 32059199)
18. Mohammadi M, McMahon G, Sun L, Tang C, Hirth P, Yeh BK, Hubbard SR, Schlessinger J (1997) Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors. Science 276:955-960 (Pubitemid 27209095)
19. Mohammadi M, Froum S, Hamby JM, Schroeder MC, Panek RL, Lu GH, Eliseenkova AV, Green D, Schlessinger J, Hubbard SR (1998) Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain. EMBO J 17:5896-5904 (Pubitemid 28474784)
20. Hasan J, Byers R, Jayson GC (2002) Intra-tumoural microvessel density in human solid tumours. Br J Cancer 86:1566-1577 (Pubitemid 34628110)
21. Nico B, Benagiano V, Mangieri D, Maruotti N, Vacca A, Ribatti D (2008) Evaluation of microvascular density in tumors: pro and contra. Histol Histopathol 23:601-607 (Pubitemid 351559267)
22. Presta M, Andres G, Leali D, Dell'Era P, Ronca R (2009) Inflammatory cells and chemokines sustain FGF2-induced angiogenesis. Eur Cytokine Netw 20:39-50
23. Tigges U, Hyer EG, Scharf J, Stallcup WB (2008) FGF2-dependent neovascularization of subcutaneous Matrigel plugs is initiated by bone marrow-derived pericytes and macrophages. Development 135:523-532